BACKGROUND: Lead is classified as a probable human carcinogen. However, its role in renal cell cancer (RCC) has not been established. Calcium and vitamin D may off-set toxicity in vivo. METHODS: In this nested case-control study, whole blood lead, total serum calcium, and serum 25-hydroxyvitamin D levels were measured in blood drawn prior to diagnosis among male smokers participating in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Single-nucleotide polymorphisms (SNP) in five genes (CALB1, TRPV5, TRPV6, VDR, and ALAD) related to lead toxicity or calcium transport were genotyped. Logistic and linear regressions were used to determine RCC risk and time to diagnosis (respectively), adjusting for other risk factors. RESULTS: Among 154 newly diagnosed cases and 308 matched controls, RCC was associated with higher whole blood lead [OR = 2.0; 95% confidence interval (CI), 1.0-3.9; quartile 4 (Q4) vs. Q1, P(trend) = 0.022] and CALB1 rs1800645 (P(trend) = 0.025, minor 'T' allele frequency = 0.34). Higher total serum calcium (P(trend) ≤ 0.001) was associated with reduced RCC risk. Total serum calcium and 25-hydroxyvitamin D levels did not alter the association observed with lead. Time from enrollment to RCC diagnosis was positively associated with serum calcium (P(trend) = 0.002) and 25-hydroxyvitamin D (P(trend) = 0.054) among cases. CONCLUSIONS: Higher blood lead concentrations, below the 10 μg/dL level of concern, were associated with RCC, independent from serum calcium and CALB1 promoter polymorphism. IMPACT: Increased risk of RCC is associated with lower serum calcium and higher whole blood lead in smokers. The clinical prognostic value of serum calcium and vitamin D in RCC should be further investigated.
BACKGROUND: Lead is classified as a probable human carcinogen. However, its role in renal cell cancer (RCC) has not been established. Calcium and vitamin D may off-set toxicity in vivo. METHODS: In this nested case-control study, whole blood lead, total serum calcium, and serum 25-hydroxyvitamin D levels were measured in blood drawn prior to diagnosis among male smokers participating in the Alpha-Tocopherol, Beta-CaroteneCancer Prevention Study. Single-nucleotide polymorphisms (SNP) in five genes (CALB1, TRPV5, TRPV6, VDR, and ALAD) related to lead toxicity or calcium transport were genotyped. Logistic and linear regressions were used to determine RCC risk and time to diagnosis (respectively), adjusting for other risk factors. RESULTS: Among 154 newly diagnosed cases and 308 matched controls, RCC was associated with higher whole blood lead [OR = 2.0; 95% confidence interval (CI), 1.0-3.9; quartile 4 (Q4) vs. Q1, P(trend) = 0.022] and CALB1rs1800645 (P(trend) = 0.025, minor 'T' allele frequency = 0.34). Higher total serum calcium (P(trend) ≤ 0.001) was associated with reduced RCC risk. Total serum calcium and 25-hydroxyvitamin D levels did not alter the association observed with lead. Time from enrollment to RCC diagnosis was positively associated with serum calcium (P(trend) = 0.002) and 25-hydroxyvitamin D (P(trend) = 0.054) among cases. CONCLUSIONS: Higher blood lead concentrations, below the 10 μg/dL level of concern, were associated with RCC, independent from serum calcium and CALB1 promoter polymorphism. IMPACT: Increased risk of RCC is associated with lower serum calcium and higher whole blood lead in smokers. The clinical prognostic value of serum calcium and vitamin D in RCC should be further investigated.
Authors: Toni K Choueiri; Jorge A Garcia; Paul Elson; Mohamad Khasawneh; Saif Usman; Ali Reza Golshayan; Rachid C Baz; Laura Wood; Brian I Rini; Ronald M Bukowski Journal: Cancer Date: 2007-08-01 Impact factor: 6.860
Authors: Veronica Wendy Setiawan; Daniel O Stram; Abraham M Y Nomura; Laurence N Kolonel; Brian E Henderson Journal: Am J Epidemiol Date: 2007-07-26 Impact factor: 4.897
Authors: Greicy M M Conterato; Paula R Augusti; Sabrina Somacal; Lídia Einsfeld; Rocheli Sobieski; Juliana R V Torres; Tatiana Emanuelli Journal: Basic Clin Pharmacol Toxicol Date: 2007-08 Impact factor: 4.080
Authors: Susan E Schober; Lisa B Mirel; Barry I Graubard; Debra J Brody; Katherine M Flegal Journal: Environ Health Perspect Date: 2006-10 Impact factor: 9.031
Authors: David A Hughes; Kun Tang; Rainer Strotmann; Torsten Schöneberg; Jean Prenen; Bernd Nilius; Mark Stoneking Journal: PLoS One Date: 2008-02-27 Impact factor: 3.240
Authors: Hongke Wu; Stephanie Weinstein; Lee E Moore; Demetrius Albanes; Robin Taylor Wilson Journal: Cancer Causes Control Date: 2021-10-15 Impact factor: 2.506
Authors: Catherine L Callahan; Sarah J Locke; Pamela J Dopart; Patricia A Stewart; Kendra Schwartz; Julie J Ruterbusch; Barry I Graubard; Nathaniel Rothman; Jonathan N Hofmann; Mark P Purdue; Melissa C Friesen Journal: Am J Ind Med Date: 2018-10-06 Impact factor: 2.214
Authors: Linda M Liao; Melissa C Friesen; Yong-Bing Xiang; Hui Cai; Dong-Hee Koh; Bu-Tian Ji; Gong Yang; Hong-Lan Li; Sarah J Locke; Nathaniel Rothman; Wei Zheng; Yu-Tang Gao; Xiao-Ou Shu; Mark P Purdue Journal: Environ Health Perspect Date: 2015-06-19 Impact factor: 9.031
Authors: Ryan Akin; David Hannibal; Margaret Loida; Emily M Stevens; Elizabeth A Grunz-Borgmann; Alan R Parrish Journal: Int J Mol Sci Date: 2019-12-14 Impact factor: 5.923